Treace Medical Concepts, Inc.

NasdaqGS:TMCI Stock Report

Market Cap: US$429.0m

Treace Medical Concepts Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:TMCI Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
04 Mar 25BuyUS$524,064John TreaceIndividual60,000US$8.73
16 Sep 24BuyUS$265,630John TreaceIndividual50,000US$5.31
15 Aug 24BuyUS$501,035James TreaceIndividual84,000US$5.96
14 Aug 24BuyUS$510,315John TreaceIndividual85,000US$6.00
11 Jun 24BuyUS$264,600John TreaceIndividual45,000US$5.88
31 May 24BuyUS$151,328James TreaceIndividual25,000US$6.05
29 May 24BuyUS$130,063James TreaceIndividual25,000US$5.20
28 May 24BuyUS$253,475James TreaceIndividual50,000US$5.07
24 May 24BuyUS$93,501Richard MottIndividual18,000US$5.19
22 May 24BuyUS$60,425Richard MottIndividual12,100US$4.99
17 May 24BuyUS$556,170John TreaceIndividual100,000US$5.56
14 May 24BuyUS$767,805John TreaceIndividual150,000US$5.12
14 May 24BuyUS$100,001Jane KiernanIndividual19,356US$5.17
13 May 24BuyUS$1,370,370John TreaceIndividual300,000US$4.58
13 May 24BuyUS$1,034,004James TreaceIndividual228,000US$4.54
13 May 24BuyUS$540,939Richard MottIndividual120,000US$4.57

Insider Trading Volume

Insider Buying: TMCI insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of TMCI?
Owner TypeNumber of SharesOwnership Percentage
Hedge Funds6,209,0009.87%
General Public9,770,81115.5%
Individual Insiders15,229,71024.2%
Institutions31,695,43150.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 74.33% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
18.6%
John Treace
11,704,787US$79.8m0.46%no data
9.87%
Armistice Capital LLC
6,209,000US$42.3m0.21%1.11%
6.15%
BlackRock, Inc.
3,868,055US$26.4m2.49%no data
4.88%
William Blair Investment Management, LLC
3,070,692US$20.9m4.13%0.03%
4.3%
The Vanguard Group, Inc.
2,705,023US$18.4m-1.01%no data
3.33%
Morgan Stanley, Investment Banking and Brokerage Investments
2,091,809US$14.3m-34.9%no data
3%
CIBC Private Wealth Advisors, Inc.
1,888,266US$12.9m0%0.02%
2.83%
James Treace
1,779,624US$12.1m0%no data
2.78%
Gagnon Securities, LLC
1,746,536US$11.9m-1.21%2.62%
2.37%
JP Morgan Asset Management
1,493,278US$10.2m48.5%no data
2.04%
Deutsche Asset & Wealth Management
1,284,174US$8.8m-0.38%no data
1.77%
D. E. Shaw & Co., L.P.
1,115,826US$7.6m-2.46%0.01%
1.69%
Geode Capital Management, LLC
1,062,765US$7.2m2.13%no data
1.68%
Richard Mott
1,057,853US$7.2m0%no data
1.54%
UBS Asset Management AG
968,434US$6.6m378%no data
1.54%
State Street Global Advisors, Inc.
966,432US$6.6m-3.11%no data
0.78%
Gagnon Advisors, LLC
489,891US$3.3m0%2.51%
0.76%
John Bakewell
477,348US$3.3m0%no data
0.75%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
471,331US$3.2m0%no data
0.75%
Northern Trust Global Investments
468,894US$3.2m2.34%no data
0.67%
Point72 Asset Management, L.P.
419,663US$2.9m29.3%0.01%
0.6%
Charles Schwab Investment Management, Inc.
380,411US$2.6m8.84%no data
0.58%
Kornitzer Capital Management, Inc.
365,393US$2.5m-30.7%0.05%
0.55%
JPMorgan Chase & Co, Brokerage and Securities Investments
344,120US$2.3m118%no data
0.52%
Millennium Management LLC
328,773US$2.2m-40.7%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/12 22:46
End of Day Share Price 2025/05/12 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Treace Medical Concepts, Inc. is covered by 10 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael GormanBTIG
Lilia-Celine LozadaJ.P. Morgan
Robert MarcusJ.P. Morgan